PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 11 results · Off-label Promotion · Immunology & Rheumatology  · Clear
🔒 Subscribers only
AUTH/3650/5/22
Off-label Promotion Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Eli Lilly v UCB
Eli Lilly complained about three claims in a UCB promotional leavepiece for Bimzelx (bimekizumab) aimed at dermatology health professionals (Sept 2021 leavepiece ref IL-P-BK-PSD-2100004; updated No…
🔒 Subscribers only
AUTH/3313/2/20
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts
A UK health professional complained about a journal advertisement for Octasa 1600mg (modified release mesalazine) placed by Tillotts Pharma UK Limited (ref PU-00264) in the January 2020 edition of …
Clauses: NONE
🔒 Subscribers only
AUTH/2888/11/16
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Napp
A hospital specialist nurse complained about a promotional email from Napp Pharmaceuticals Limited about switching from Remicade (originator infliximab) to Remsima (biosimilar infliximab).Email sub…
Clauses: NONE
🔒 Subscribers only
AUTH/2923/12/16
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Merck Sharp & Dohme
A hospital pharmacist complained about a two-page Remicade (infliximab) advertisement by Merck Sharp & Dohme, published in The Pharmaceutical Journal (Oct–Dec 2016).Page 1 featured an intact …
Clauses: NONE
🔒 Subscribers only
AUTH/2801/11/15
Off-label Promotion Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag voluntarily admitted that a two-page bound insert advertisement for Stelara (ustekinumab) in the Annals of Rheumatic Disease (ARD) October 2015 issue contained outdated prescribing in…
Clauses: 4.9,9.1
🔒 Subscribers only
AUTH/2610/6/13
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts Pharma
Warner Chilcott UK complained about Tillotts Pharma UK’s promotion of Octasa (mesalazine modified-release tablets) via a journal supplement (ref UK/OC/0001/0113) published in the British Journal …
Clauses: NONE
🔒 Subscribers only
AUTH/2267/9/09
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Shire v Procter & Gamble
Shire complained about Procter & Gamble promotional materials for Asacol (modified release mesalazine): two leavepieces and a journal advertisement.Asacol’s indications included treatment of …
Clauses: NONE
🔒 Subscribers only
AUTH/2122/5/08
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Bayer Schering Pharma — Nebido (long-acting testosterone injection)
An anonymous ex-employee complained about an advertisement for Nebido (long-acting testosterone injection) published in the BMJ on 3 May 2008.The complainant alleged the ad implied Nebido would ena…
Clauses: 2,3.2,9.1
🔒 Subscribers only
AUTH/2005/5/07
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Pfizer
A general practitioner complained about a Pfizer journal advertisement for Celebrex (celecoxib) published in Geriatric Medicine, May 2007 (ad code COX459h).The complaint focused on the line “I ne…
Clauses: NONE
🔒 Subscribers only
AUTH/1898/10/06
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Procter & Gamble
Two general practitioners complained about a ‘Dear Doctor’ letter from a university hospital professor about prescribing oral mesalazine preparations.The letter stated it was “sponsored by an…
Clauses: NONE
🔒 Subscribers only
AUTH/1855/6/06
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Roche
Novartis complained about a Roche promotional booklet for CellCept (mycophenolate mofetil) titled “Are you concerned about GI complications after transplantation?” (ref P212582/1105), used by h…
Clauses: NONE
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews